Tyto Insights for Rhonchi Detection
Tyto Care , Ltd. is listed for Tyto Insights for Rhonchi Detection (K243567). The FDA list gives April 7, 2025 as the date of the final decision. The lead panel is Anesthesiology, and the database link on the FDA list is the 510(k) pathway. openFDA describes product code PHZ as “Abnormal Breath Sound Device”: The device is intended to measure abnormal breath sound, such as wheeze, rhonchi, and whistling. openFDA records this submission’s decision description as “Substantially Equivalent.” This paragraph is assembled only from those public fields. It is not an FDA review, not a determination of safety or effectiveness, and not medical advice. Official record: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K243567
- Date of final decision
- April 7, 2025
- Company on the FDA list
- Tyto Care , Ltd.
- Lead panel
- Anesthesiology
- Primary product code
- PHZ
- openFDA device name for the code
- Abnormal Breath Sound Device
- Device class
- 2
- Regulation number
- 868.1900
- openFDA decision description
- Substantially Equivalent
- openFDA decision code
- SESE
- Statement or summary label
- Summary
Product-code text from openFDA
The device is intended to measure abnormal breath sound, such as wheeze, rhonchi, and whistling.